Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18837952 | 0.97 | LMNA (0.41) | LMNA | |
| SCHEMBL35169 | 0.97 | LMNA (0.44) | LMNA | |
| SCHEMBL8130395 | 0.97 | LMNA (0.44) | LMNA | |
| SCHEMBL9717789 | 0.93 | LMNA (0.43) | LMNA | |
| Ammonia Solution, Strong SCHEMBL819686 | 0.93 | LMNA (0.43) | LMNA | |
| Water SCHEMBL1968372 | 0.93 | LMNA (0.43) | LMNA | |
| SCHEMBL30297175 | 0.93 | LMNA (0.43) | LMNA | |
| Ammonia Solution, Strong SCHEMBL5798615 | 0.93 | LMNA (0.43) | LMNA | |
| Ammonia Solution, Strong SCHEMBL6654953 | 0.90 | LMNA (0.46) | LMNA | |
| Ammonia Solution, Strong SCHEMBL6654767 | 0.90 | LMNA (0.46) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597789-B2 | Materials for hydrophilic interaction chromatography and processes for preparation and use thereof for analysis of glycoproteins and glycopeptides | WATERS TECHNOLOGIES CORPORATION (US) | 2023-03-07 | — | — | US | claimed |
| US-12565567-B2 | Multifunctional smart particles | SYNMATTER LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260054250-A1 | COMPOSITE PARTICLES WITH NON-POROUS HYBRID ORGANIC-INORGANIC MATERIAL | WATERS TECHNOLOGIES CORPORATION (US) | 2026-02-26 | — | — | US | disclosed |
| US-20240239968-A1 | Multifunctional Smart Particles | SYNMATTER LLC (US) | 2024-07-18 | — | — | US | disclosed |
| US-11926716-B2 | Multifunctional smart particles | SYNMATTER LLC (US) | 2024-03-12 | — | — | US | disclosed |
| EP-3674368-B1 | METAL RESIN COMPOSITE BODY, RESIN COMPOSITION AND METHOD FOR PRODUCING METAL RESIN COMPOSITE BODY | MITSUBISHI ENG PLASTICS CORP (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-116376137-A | Polyethylene master batch, preparation method and antistatic polyethylene pipe | 廊坊北化高分子材料有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20230120425-A1 | Multifunctional Smart Particles | SYNMATTER LLC (US) | 2023-04-20 | — | — | US | disclosed |
| WO-2023058454-A1 | ANTIREFLECTION LAMINATE | フクビ化学工業株式会社 | 2023-04-13 | — | — | WO | disclosed |
| CN-110191701-B | Composition for enhancing protein strength | 株式会社LG生活健康 | 2023-02-21 | — | — | CN | disclosed |
| US-7374684-B2 | Method of separating components in a sample using silane-treated silica filter media | DOW CORNING CORPORATION (US) | 2008-05-20 | — | — | US | disclosed |
| US-20070292181-A1 | Image holding member and image forming apparatus | FUJI XEROX CO., LTD. | 2007-12-20 | — | — | US | disclosed |
| US-20070267349-A1 | METHOD OF SEPARATING COMPONENTS IN A SAMPLE USING SILANE-TREATED SILICA FILTER MEDIA | DOW CORNING CORPORATION | 2007-11-22 | — | — | US | disclosed |
| US-7264728-B2 | Method of separating components in a sample using silane-treated silica filter media | DOW CORNING CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| WO-2007084245-A2 | SYSTEMS AND METHODS FOR FUNCTIONALIZING PARTICULATES SILANE-CONTAINING MATERIALS | DOW CORNING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20050029195-A1 | Method of separating components in a sample using silane-treated silica filter media | DOW CORNING CORPORATION | 2005-02-10 | — | — | US | disclosed |
| EP-0617345-B1 | Intermediate transfer element coatings | XEROX CORP (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0617345-A1 | Intermediate transfer element coatings | XEROX CORPORATION (US) | 1994-09-28 | — | — | EP | disclosed |
| EP-0574381-A1 | SILANE PRIMER COMPOSITION. | AMERICAN STANDARD INC (US) | 1993-12-22 | — | — | EP | disclosed |
| WO-1992010531-A1 | SILANE PRIMER COMPOSITION | AMERICAN STANDARD INC. (US) | 1992-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565567-B2 | Multifunctional smart particles | KCNN3, KCNN1, KCNN2 | LMNA 2914/4885 |
| US-20260054250-A1 | COMPOSITE PARTICLES WITH NON-POROUS HYBRID ORGANIC-INORGANIC MATERIAL | FLNB, FLNA, CFD | LMNA 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.